PATENT CLAIM ANALYSIS

Application Number: 16051162
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "411000"]

Abstract:
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C 12 /C max  ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.

Claim (Index 71):
The dosage form of  claim 65 , wherein said hydrocodone plasma concentrations are hydrocodone plasma concentrations from first administration of the dosage form to a fed human.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 95.0
- Lexical Diversity: 1.5283
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15376868', '15376851', '15376799', '14635198', '14483395']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8087162219120521
- 35 USC 102 Novelty (BERT): 0.5753740937894462
- Combined Prediction Score: 0.7853820090997915
- Mean Citation Score: 511.342706
- Max Citation Score: 530.4666
- Similarity Product: 374.0795534923912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test